Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report
Keyword(s):
2020 ◽
Vol 9
(3)
◽
pp. 787-792
◽
2018 ◽
Vol 5
(1)
◽
pp. 1-4
Keyword(s):
Keyword(s):
Keyword(s):